Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention

NCT ID: NCT01889030

Last Updated: 2014-07-24

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 516 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2013-07-31
• Study Completion Date: 2014-06-30

Brief Summary

This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.

The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).

Detailed Description

This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.

The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).

Conditions

Cardiovascular Primary Prevention

Study Design

• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Target population

This observational, cross-sectional, national multicenter designed study will describe the frequency of use of different evaluation methods (risk scores or subjective assessment) employed to determine the cardiovascular risk of patients in a primary care setting, at both General Practitioners (GPs) or Cardiologists offices.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Patients older than 18 years of age, who give their written consent to take part.
• Patients without known vascular disease (primary prevention) under follow-up by the investigator, whose medical records have been initiated during the last 3 years.
• Patients who have completed their baseline CV risk assessment Lipid lowering treatment naive patients at the time of the stratification.

Exclusion Criteria

• Incomplete or missing medical record data.
• Subjects with prior cardiovascular disease (peripheral vascular disease, coronary or cerebrovascular disease) symptomatic or asymptomatic.
• Subjects with terminal status disease or short life expectancy.
• Hypothyroidism without proper control.
• Pregnancy.
• Medical records compiled within a period longer than 3 years to the date of inclusion.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

AstraZeneca

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Research Site

Buenos Aires, , Argentina

Countries

Argentina

Other Identifiers

NIS-CAR-XXX-2013/1

Identifier Type: -

Identifier Source: org_study_id